Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Korean Study Links Weight-Loss Drugs to Higher Depression and Suicidal Thoughts
- 1866 storm rescue recreation part of festivities
- 6 Hidden Gems in Brazil for Retirees Seeking a Serene, Affordable Lifestyle
- ‘Mothers get lost in the shuffle’: The Clancy trial highlights gaps in postpartum mental health care
- Analytic Philosophy Is the Ideology of the Status Quo
- J-16 fighters fly 3,700 miles for China
- Frontier Health launches campaign to support domestic violence shelter
- No new H1N1 strain in India, existing vaccines sufficient, says ICMR
Browsing: vaccines
The Indian Council of Medical Research (ICMR) on Sunday (August 23, 2026) said that the Influenza A (H1N1) viruses currently circulating in the country belong to the A/Missouri/11/2025 (H1N1) pdm09-like virus strain. It clarified that no new strain of H1N1 has been identified and there is no cause for panic
The World Health Organization estimates that in 2026 nearly 11 million people will contract the virus that causes measles. Most of these cases will occur in Africa and Asia, but many countries in the Americas and Europe are reporting outbreaks affecting hundreds or thousands of people
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the potential of Moderna’s melanoma vaccine breakthrough on CBS News 24/7’s The Daily Report on Aug. 19, drawing on her experience as a former melanoma patient
EL PASO, TEXAS (KFOX14/CBS4) —A resurgence of whooping cough cases in El Paso is raising concerns among public health officials as vaccination rates decline locally and across the country
Last week, the government of the Democratic Republic of the Congo (DRC) requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group on Vaccine Provision (ICG). The request was for use of the vaccine in the current Bundibugyo virus disease outbreak. Ervebo vaccine is licensed…
ASU researchers used AI to analyze antibodies already present in the blood, uncovering patterns that may reveal a person’s “immune readiness” before vaccination. The findings could eventually help identify who is likely to mount a strong response — and who may need additional protection. Graphic by Jason Drees/ASU
View more blogs related to Conditions and ServicesView more blogs related to Chest and BackView more blogs related to Heart and Vascular SystemView more blogs related to Primary Care
BMJ Public Health has retracted a paper some — including a witness at a recent U.S. Senate subcommittee hearing — have used to link COVID-19 vaccines to deaths. The action comes more than two years after a researcher cited in the work flagged issues with the study.
ByAmanda Greenwood Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.
Over the next few weeks, millions of young children across America will walk through the schoolhouse doors for their first day of kindergarten. They’ll have backpacks on their shoulders, butterflies in their bellies and smiles on their faces

